NCT03349086

Brief Summary

The purpose of this study is to assess the effect of voice exercise and voice rest on subject's perception of vocal handicap and communicative participation following Botox injections for adductor spasmodic dysphonia.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2014

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 28, 2014

Completed
3.1 years until next milestone

First Submitted

Initial submission to the registry

August 31, 2017

Completed
3 months until next milestone

First Posted

Study publicly available on registry

November 21, 2017

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 25, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 25, 2018

Completed
Last Updated

May 23, 2019

Status Verified

May 1, 2019

Enrollment Period

4 years

First QC Date

August 31, 2017

Last Update Submit

May 21, 2019

Conditions

Keywords

Botox InjectionSpasmodicDysphoniaVoice TherapySpeech TherapyVoice Rest

Outcome Measures

Primary Outcomes (1)

  • A quantifiable difference between the effects of voice exercise vs. voice rest post Adductor Spasmodic Dysphonia botox treatment through analysis of the Voice Handicap Index Questionnaire.

    Pre randomized condition and post 6 week and 12 week, participants will be asked to complete the Voice Handicap Index (VHI). The VHI Questionnaire (Voice Handicap Index) is a 30-item questionnaire divided into 3 subsections (Functional, Physical, Emotional) and a Total which measures the effect of voice problems on quality of life. Individuals mark each item on this 30-item questionnaire on a scale from 0-4 (0 being never and 4 being always). Points for each subscale are tallied and a total composite score is also given. A total score of 0-11 is considered Normal, 12-28 is considered Mild Minimal handicap, 29-56 is considered Moderate Handicap, and 57-120 is considered severe handicap.

    Assessing the change of the post VHI questionnaire between groups. Data will be reported at study completion, an average of 1 year.

Study Arms (2)

Voice Exercise

ACTIVE COMPARATOR

Randomized participants in this group will undergo 45 minutes of voice exercise, including sustained pitches and pitch glides on a variety of different vocal facilitators.

Behavioral: Voice Exercise

Voice Rest

NO INTERVENTION

Randomized participants in this group will undergo 45 minutes of voice rest.

Interventions

Voice ExerciseBEHAVIORAL

Voice exercise will consist of sustained pitches and pitch glides on a variety of different vocal facilitators.

Voice Exercise

Eligibility Criteria

Age21 Years - 70 Years
Sexfemale(Gender-based eligibility)
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Female
  • age
  • Diagnosed with pure adductor spasmodic dysphonia
  • Completed 2 consecutive standard of care Botox injection into the thyroarytenoid (TA) and/or thyroarytenoid/lateral cricoarytenoid (TA/LCA) junction with the same dosage

You may not qualify if:

  • Receiving Botox to other laryngeal or supraglottic musculature
  • Other neuro-laryngological conditions
  • Those with an average of less than two injections per year

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Wisconsin - Madison

Madison, Wisconsin, 53792, United States

Location

MeSH Terms

Conditions

DysphoniaCommunication Disorders

Condition Hierarchy (Ancestors)

Voice DisordersLaryngeal DiseasesRespiratory Tract DiseasesOtorhinolaryngologic DiseasesNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsNeurobehavioral ManifestationsNeurodevelopmental DisordersMental Disorders

Study Officials

  • Brienne Ruel, MS

    University of Wisconsin, Madison

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Participants will undergo one of two study conditions immediately following a standard of care Botox injections. One condition is a 45 minute voice rest condition and the other condition is a 45 minute voice exercise condition.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 31, 2017

First Posted

November 21, 2017

Study Start

July 28, 2014

Primary Completion

July 25, 2018

Study Completion

July 25, 2018

Last Updated

May 23, 2019

Record last verified: 2019-05

Data Sharing

IPD Sharing
Will not share

Locations